These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7879494)

  • 1. [The isolation and purification of a staphylococcal exotoxin in toxic shock and the production of antisera].
    Tekut'ev SI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):105-6. PubMed ID: 7879494
    [No Abstract]   [Full Text] [Related]  

  • 2. [Staphylococcal toxic shock exotoxin (its isolation and characteristics)].
    Akatov AK; Fluer FS; Ratgauz GL; Kushko IV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):15-20. PubMed ID: 3541462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal pyrogenic exotoxin type C: further characterization.
    Schlievert PM; Kelly JA
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):982-6. PubMed ID: 7091979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An immunoenzyme test system for determining the staphylococcal exotoxin of toxic shock].
    Fluer FS; Mikheeva GV; Pozhar PF; Akatov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):70-3. PubMed ID: 2099074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A rapid method of detecting the staphylococcal exotoxin of toxic shock].
    Fluer FS; Pozhar PF; Ratgauz GL; Akatov AK
    Lab Delo; 1989; (4):62-4. PubMed ID: 2470975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of Staphylococcus aureus FRI 1169 and 587 toxic shock syndrome exotoxins.
    Igarashi H; Fujikawa H; Usami H; Kawabata S; Morita T
    Infect Immun; 1984 Apr; 44(1):175-81. PubMed ID: 6200439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological properties of toxic shock syndrome exotoxin.
    Schlievert PM
    Surv Synth Pathol Res; 1984; 3(1):54-62. PubMed ID: 6505480
    [No Abstract]   [Full Text] [Related]  

  • 8. [A study on the pathogenesis of Streptococcus mitis exotoxin].
    Lu H; Weng X; Yin Y; Chen Y; Jiang X; Wang H; Qian K; Zhu B; Peng B; Gong Z
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):29-31. PubMed ID: 11798555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production.
    Schlievert PM; Kelly JA
    J Infect Dis; 1984 Mar; 149(3):471. PubMed ID: 6715902
    [No Abstract]   [Full Text] [Related]  

  • 10. Chitosan malate inhibits growth and exotoxin production of toxic shock syndrome-inducing Staphylococcus aureus strains and group A streptococci.
    Schlievert PM
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3056-62. PubMed ID: 17576832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation of a type C2 staphylococcal antienterotoxic serum].
    Fluer FS
    Vopr Pitan; 1985; (1):70-2. PubMed ID: 3885569
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification and characterization of staphylococcal pyrogenic exotoxin type B.
    Schlievert PM
    Biochemistry; 1980 Dec; 19(26):6204-8. PubMed ID: 6781533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Toxic shock syndrome].
    Hartemann E
    Pediatrie; 1983; 38(7):497-502. PubMed ID: 6366730
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors.
    Schlievert PM; Blomster DA
    J Infect Dis; 1983 Feb; 147(2):236-42. PubMed ID: 6827140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic studies on Staphylococcal strains from patients with toxic shock syndrome.
    Kreiswirth BN; Novick RP; Schlievert PM; Bergdoll M
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):974-7. PubMed ID: 6212007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and biological properties of a new staphylococcal exotoxin.
    Ren K; Bannan JD; Pancholi V; Cheung AL; Robbins JC; Fischetti VA; Zabriskie JB
    J Exp Med; 1994 Nov; 180(5):1675-83. PubMed ID: 7964453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
    Smith RJ; Schlievert PM; Himelright IM; Baddour LM
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production.
    Schlievert PM; Blomster DA; Kelly JA
    Obstet Gynecol; 1984 Nov; 64(5):666-71. PubMed ID: 6436761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Production of toxic shock exotoxin by Staphylococcus aureus strains resistant and sensitive to antibiotics].
    Akatov AK; Pozhar PF; Ratgauz GL; Fluer FS; Litvinov OM; Parchinskaia IA
    Antibiot Khimioter; 1989 Aug; 34(8):569-72. PubMed ID: 2589896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.
    Schlievert PM; Shands KN; Dan BB; Schmid GP; Nishimura RD
    J Infect Dis; 1981 Apr; 143(4):509-16. PubMed ID: 6972418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.